Good News! EClinCloud Wins First Prize at the Inaugural AI-Empowered Industry Competition

At the recently concluded inaugural "AI Ningbo" AI-Empowered Industry Competition, EClinCloud stood out from 1190 projects across more than 20 countries and regions worldwide, winning the competition's highest award, First Prize (with no Grand Prize awarded), and receiving associated funding support.
This competition, which tested core AI technical capabilities, fully validated EClinCloud's technical foundation and implementation capabilities in "AI + clinical trials" and demonstrated its strong product capabilities and potential for industry leadership.
Using AI to Empower the Full Clinical Drug Development Process
Across the full lifecycle of new drug R&D, EClinCloud has built an intelligent, integrated cloud platform based on core products such as
EDC, eCOA, CTMS, eTMF, RTSM, and IRC, breaking down data silos and achieving end-to-end workflow collaboration.
Meanwhile, EClinCloud relies on its self-developed
AI technology platform and in-house large models to deeply integrate AI into key stages such as data analysis and risk prediction, building intelligent decision-support and drug R&D prediction models and comprehensively improving clinical R&D efficiency and decision-making quality.
EClinCloud Founder
& CEO Dr. Qin Long said:
"This award not only reflects the application value and prospects of AI technology in clinical research, but also validates EClinCloud's overall strength in model capabilities and product deployment. We will continue to strengthen our technical foundation and focus on real-world pain points to advance intelligent transformation across the entire clinical research workflow."


